Research

COVID-19 Research

Title :

Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome

Area of research :

COVID-19 Research, Life Sciences & Biotechnology

Focus area :

COVID-19 Therapeutics

Principal Investigator :

Dr Kamal Rawal, Associate Professor, Amity University, Uttar Pradesh

Timeline Start Year :

2020

Contact info :

Details

Executive Summary :

The study intends to develop artificial intelligence (AI) driven, integrative, antiviral drug repurposing platform.

Outcome/Output:

A web enabled resource for COVID-19 datasets, information and software has been created for the benefit of the scientific community. Further, a patient-centric cloud-based system to capture side effects and therapeutics of existing drugs used for COVID-19 treatment has been deployed.

Organizations involved